RSV prophylaxis guideline changes and outcomes in children with congenital heart disease.

Adam S WalpertIan D ThomasMerlin C LoweMichael David Seckeler

Published in: Congenital heart disease (2018)

Our findings provide additional support for the new guideline recommendations to provide respiratory syncytial virus prophylaxis only for children ≤12 months old with congenital heart disease.

Keyphrases

respiratory syncytial virus
young adults
type diabetes
clinical practice
adipose tissue
metabolic syndrome
insulin resistance
skeletal muscle